Insider Trading & Ownership - Noonberg Sarah B.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Noonberg Sarah B.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-02-10
Sale
2021-02-12
6:36 pm
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
8,400$25.3$212,55510,900
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-18
Option Award
2024-06-20
4:27 pm
N/A
2034-06-18
MARINUS PHARMACEUTICALS INC.MRNSNoonberg Sarah B.
Director
12,750$024,550
(Direct)
View
2024-06-14
Option Award
2024-06-17
2:36 pm
N/A
2034-06-14
Neurogene Inc.NGNENoonberg Sarah B.
Director
7,700$07,700
(Direct)
View
2024-04-01
Option Award
2024-04-03
8:47 pm
N/A
2034-03-31
Metagenomi Inc.MGXNoonberg Sarah B.
Chief Medical Officer
300,638$0343,249
(Direct)
View

Ownership
2024-02-08
7:26 pm
N/A
N/A
Metagenomi Inc.MGXNoonberg Sarah B.
Chief Medical Officer
0$042,611
(Direct)
View
2024-01-18
Option Award
2024-01-19
4:28 pm
N/A
2034-01-18
MARINUS PHARMACEUTICALS INC.MRNSNoonberg Sarah B.
Director
25,500$032,700
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:56 pm
N/A
2034-01-16
Neurogene Inc.NGNENoonberg Sarah B.
Director
15,400$015,400
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:26 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXNoonberg Sarah B.
Director
25,000$025,000
(Direct)
View
2023-05-16
Option Award
2023-05-17
9:08 pm
N/A
2033-05-16
MARINUS PHARMACEUTICALS INC.MRNSNoonberg Sarah B.
Director
39,600$039,600
(Direct)
View
2023-01-16
Option Award
2023-01-18
8:03 pm
N/A
2033-01-15
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
30,000$030,000
(Direct)
View
2022-05-26
Option Award
2022-05-27
4:01 pm
N/A
2032-05-26
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
20,000$020,000
(Direct)
View
2022-05-12
Option Award
2022-05-16
6:24 pm
N/A
2032-05-11
Neoleukin Therapeutics Inc.NLTXNoonberg Sarah B.
Director
25,000$025,000
(Direct)
View
2021-05-27
Option Award
2021-05-28
6:43 pm
N/A
2031-05-26
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
18,000$018,000
(Direct)
View
2021-05-11
Option Award
2021-05-13
5:37 pm
N/A
2031-05-10
Neoleukin Therapeutics Inc.NLTXNoonberg Sarah B.
Director
25,000$025,000
(Direct)
View
2021-02-10
Exercise
2021-02-12
6:36 pm
N/A
2028-05-28
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
8,400$010,900
(Direct)
View
2021-02-10
Option Award
2021-02-12
6:36 pm
N/A
N/A
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
8,400$6.9810,900
(Direct)
View
2020-05-28
Option Award
2020-05-29
6:16 pm
N/A
2030-05-27
Protagonist Therapeutics IncPTGXNoonberg Sarah B.
Director
15,000$015,000
(Direct)
View
2020-05-05
Option Award
2020-05-07
4:26 pm
N/A
2030-05-05
Neoleukin Therapeutics Inc.NLTXNoonberg Sarah B.
Director
25,000$025,000
(Direct)
View